The patterns that led to past pandemics haven’t disappeared. They’ve intensified. The same forces that drove disease emergence throughout history continue to shape our present and threaten our future. Understanding these patterns and building robust systems to detect and respond to emerging threats isn’t just about looking backward-it’s about ensuring we’re prepared for what comes next.
Table of Contents
- Historical patterns that continue today
- The critical role of global surveillance systems
- Genomic surveillance as a game-changer
- International cooperation and data sharing
- Future directions: prevention through prediction and ecology
- Predictive epidemiology and pathogen ecology
- One Health approaches and sustainable practices
- Building capacity and resilience
Historical patterns that continue today
The twenty-first century has witnessed a wave of severe infectious disease outbreaks, from SARS to COVID-19, the 2009 swine flu pandemic, and the Ebola epidemic in West Africa. These events share common drivers with historical disease emergence: human movement, environmental change, and contact with animal reservoirs. What has changed is the scale and speed at which these drivers operate.
Urbanization remains one of the most significant factors in disease transmission. More than 50% of the world’s population now lives in cities, creating unprecedented opportunities for pathogen spread. High population density increases exposure to respiratory and fecal-oral transmitted diseases, with urban centers typically showing higher rates of tuberculosis and other infections compared to rural areas. Densely populated cities provide favorable conditions for emerging diseases to spread rapidly, as demonstrated by SARS and H1N1 influenza epidemics.
Globalization has transformed disease dynamics in ways our ancestors could never have imagined. Airline flights have doubled since 2000, creating pathways for pathogens to circle the globe within hours. International tourist arrivals increased from 25.3 million in 1950 to 924 million in 2008, providing new opportunities for diseases like chikungunya to spread across continents. This increased mobility has made cities major entry points for travelers and, consequently, for infectious diseases.
Three interrelated trends are exacerbating zoonotic risks: income growth, urbanization, and globalization. Income growth drives increased animal protein consumption in developing countries, leading to the conversion of wild lands to livestock production and increasing the probability of zoonotic emergence. More than 60% of the 335 emerging infectious diseases recognized between 1940 and 2004 were zoonotic diseases, highlighting how human influence on ecosystems creates meeting points for new pathogens.
The critical role of global surveillance systems
Early detection of disease outbreaks can mean the difference between a contained incident and a global pandemic. Modern surveillance systems increasingly rely on advanced technologies, particularly genomic sequencing, to track and understand pathogen evolution in real time.
Genomic surveillance as a game-changer
The WHO launched a 10-year global genomic surveillance strategy in 2022 to foster collaboration between regional and international disease control programs. Genomic surveillance-the process of constantly monitoring pathogens and analyzing their genetic similarities and differences-has proven essential for detecting variants, tracking transmission patterns, and informing public health responses.
The COVID-19 pandemic demonstrated the power of genomic surveillance at an unprecedented scale. By the end of 2024, more than 17 million SARS-CoV-2 virus genomes were catalogued globally, roughly one third from laboratories in the United States. This rapid sharing of pathogen genomic data enabled the global public health community to monitor virus evolution and transmission, providing critical insights for variant surveillance and outbreak response.
Genome-wide pathogen typing and surveillance has been implemented in many national and international action plans and is supported by leading health organizations including WHO, the U.S. CDC, and the European Centre for Disease Prevention and Control. These systems have successfully been deployed for foodborne and sexually transmissible pathogens, tuberculosis, and antimicrobial resistance monitoring.
International cooperation and data sharing
Genomic data is only valuable if it’s shared. CDC has spent decades building surveillance infrastructure across the globe that detects novel influenza viruses worldwide. This network compares contemporary viruses to previously circulating strains to monitor genetic changes, assess risks to human health, and inform preparedness and response strategies.
However, challenges remain. During the COVID-19 pandemic, global data sharing was geographically uneven, with 63% of global sequences missing patient demographic information and more than 95% missing clinical information. In Africa during 2020, 72% of genome sequencing capacity was concentrated in just four countries, though this expanded rapidly through international coordination and resource mobilization.
Future directions: prevention through prediction and ecology
The next frontier in disease control lies not just in responding to outbreaks, but in preventing them before they occur. This requires a fundamental shift toward understanding the ecological and environmental factors that drive disease emergence.
Predictive epidemiology and pathogen ecology
Despite substantial effects on global public health, no pandemic has been predicted before infecting human beings. New approaches are attempting to change this. The Emerging Pandemic Threats program uses predictive modeling to identify regions, wildlife hosts, and human-animal interfaces most likely to propagate the next emerging zoonosis.
Modern infectious disease forecasting combines multiple data types including climate, demographics, socioeconomics, and geography with historic case counts. These models can identify hotspots of emerging infectious diseases where pathogens are most likely to occur. However, prediction remains challenging-while outbreak and re-emergence potential can be captured fairly well, sudden global emergences like influenza pandemics remain beyond current predictive capacity.
One Health approaches and sustainable practices
Effective disease prevention requires addressing the underlying drivers of emergence. The challenge to true pandemic prevention is addressing ecological drivers like the juxtaposition of livestock production and wildlife populations, and large-scale economic activities such as land use changes from tropical forest development.
The “One Health Quadripartite” supports multisectoral approaches to reduce health threats at the human-animal-ecosystem interface. This framework recognizes that human health, animal health, and environmental health are interconnected. Regional disease control centers in many WHO regions have already adopted One Health programs for disease surveillance, with genomic surveillance spanning across sectors.
In selected high-risk regions, associations between viral diversity, biological diversity, patterns of human contact with wildlife and livestock, and changes in land use are being explored to decipher the rules that govern disease emergence. This research aims to develop strategies to prevent future pandemics at the source before they infect human beings.
Building capacity and resilience
Future disease control depends on strengthening capacity at local, regional, and global levels. WHO’s genomic surveillance strategy aims to ensure that by 2032, all 194 Member States have timely access to genomic sequencing for pathogens with pandemic and epidemic potential. This requires sustained investment in infrastructure, workforce training in genomics and bioinformatics, and cross-cutting essential public health laboratory functions.
Disease prevention and control depends upon public health officials applying knowledge gained from population ecology. The theoretical tools of ecology and epidemiology may be the cornerstone in constructing future programs aimed at preventing and controlling infectious diseases throughout the world. As our world changes rapidly through climate change, urbanization, and globalization, the insights from disease ecology become even more valuable for tackling emerging and re-emerging infectious diseases.
What do you think? How can we better balance economic development with disease prevention strategies? What role should predictive modeling play in shaping public health policy for the next pandemic?
References
- https://www.nature.com/articles/s41579-021-00639-z
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5226902/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7106397/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4481042/
- https://www.who.int/initiatives/genomic-surveillance-strategy
- https://wwwnc.cdc.gov/eid/article/31/13/24-1670_article
- https://www.frontiersin.org/journals/science/articles/10.3389/fsci.2024.1298248/full
- https://www.cdc.gov/global-health/annual-report-2024/data-and-surveillance.html
- https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)61684-5/fulltext
- https://publichealth.jmir.org/2025/1/e59971
- https://royalsocietypublishing.org/doi/10.1098/rsos.190883
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3712877/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2762229/
Leave a Reply